CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies

Area of Science:

• Hematology
• Neurology
• Oncology

Background:

• Central nervous system (CNS) involvement by hematologic malignancies is a critical diagnostic challenge.
• Accurate detection of CNS localization is essential for appropriate treatment and patient management.

Purpose of the Study:

• To compare the diagnostic accuracy of flow cytometric immunophenotyping versus classic cytomorphology for CNS hematologic malignancy.
• To evaluate the impact of cerebrospinal fluid (CSF) pleocytosis and protein levels on diagnostic accuracy.

Main Methods:

• Retrospective review of 1,054 CSF samples from 219 patients analyzed for hematologic malignancy localization (2001-2004).
• Comparison of diagnostic yields between flow cytometry and cytomorphology.
• Analysis of CSF parameters (pleocytosis, protein content) in relation to diagnostic findings.

Main Results:

• Flow cytometry detected CNS localization in 73% of initial samples, compared to 32% for cytomorphology.
• Patients with positive cytomorphology showed more symptoms and pleocytosis, with a trend towards poorer survival.
• CSF pleocytosis (OR 10.1) and elevated protein (OR 2.9) significantly increased the odds of CNS localization, yet 19% of patients with normal CSF had CNS involvement.

Conclusions:

• Flow cytometry demonstrates over double the diagnostic value of cytomorphology for CNS hematologic malignancies.
• Cytomorphology provides complementary diagnostic and potential prognostic information and should be used alongside flow cytometry.